Buscopan® is the world’s number one (Source: IMS MIDAS) antispasmodic brand. Its active ingredient hyoscine butylbromide is basically a natural substance extracted from Duboisia plant species as Scopolamine (Hyoscine) and chemically modified to the quaternary ammonium compound Hyoscine Butylbromide.
As an antispasmodic product, Buscopan® acts directly on the site of abdominal pain by relaxing the muscles of the gastro-intestinal tract. This means Buscopan® relieves abdominal pain by directly treating its main cause - the abdominal cramp or spasm.
Buscopan® is available in the Middle East and North Africa region in the 10mg tablet format, and is suitable for adults and children above six years old; one to two tablets can be taken three times daily.
For more information, visit the Buscopan® website http://www.buscopan.com/
We recognise that the Internet serves the global community. The pharmaceutical industry, however, is subject to country specific regulatory considerations, which affect the information we can provide on our products. In addition, the registration status of pharmaceutical products may not be the same in the different countries in MENA and the approved product labels may also differ according to country-specific requirements. This Site is intended for residents within MENA countries. Products discussed herein may have different labelling in different countries. For a list of the locally registered products in each country of MENA please contact us through using the contact details on this website.